coxsackieviru
belong
genu
enteroviru
famili
picornavirida
one
six
serotyp
coxsackieviru
b
group
caus
broad
rang
diseas
myocard
pancreat
hepat
asept
mening
meningoenceph
gastroenter
necrot
enterocol
pneumonia
even
death
neonat
moreov
clinic
symptom
myopericard
pleurodynia
bornholm
diseas
still
distinct
associ
infect
enterovirusspecif
vaccin
therapeut
agent
avail
clinic
usag
infect
current
clinic
therapeut
method
support
treatment
revers
inflamm
allevi
symptom
mani
patient
still
larg
disappoint
although
great
number
vitro
picornaviru
replic
inhibitor
describ
shown
effect
vivo
none
approv
clinic
use
date
ribavirin
may
act
lethal
mutagen
via
incorpor
viral
rna
genom
vitro
activ
ribavirin
enterovirus
demonstr
sever
group
treatment
murin
myocard
led
significantli
decreas
myocardi
viru
titer
inflamm
necrosi
myocardi
calcif
one
side
effect
ribavirin
howev
drug
resist
hemolyt
anemia
licens
treatment
respiratori
syncyti
viru
hepat
c
viru
infect
therefor
need
antivir
therapi
effect
treat
infect
emodin
activ
compon
root
rhizom
polygonum
cuspidatum
use
tradit
chines
medicin
tcm
treat
diseas
like
liver
cirrhosi
diabet
nephropathi
atherosclerosi
tumour
number
pharmacolog
properti
includ
antimicrobi
antiinflammatori
antivir
anticanc
immunosuppress
chemoprevent
effect
suggest
moreov
increas
number
studi
includ
laboratori
extend
antivir
activ
emodin
mani
rna
dna
virus
envelop
nonenvelop
virus
phdepend
independ
virus
herp
simplex
viru
hepat
b
viru
sever
acut
respiratori
syndrom
sar
coronaviru
etc
find
crucial
understand
pharmacolog
properti
emodin
sinc
despit
extens
studi
antivir
effect
antivir
activ
emodin
viru
infect
still
incomplet
understood
studi
systemat
investig
antivir
activ
emodin
vitro
vivo
demonstr
emodin
could
inhibit
entri
replic
concentr
timedepend
manner
emodin
could
also
inhibit
apoptosi
induc
infect
vivo
studi
show
oral
administr
emodin
could
significantli
mitig
myocardi
viru
titer
patholog
lesion
induc
infect
find
suggest
emodin
may
repres
potenti
therapeut
effect
agent
infect
extract
process
high
perform
liquid
chromatographi
hplc
analysi
emodin
shown
figur
separ
emodin
carri
acclaim
column
mm
mm
mobil
phase
phosphor
acid
flow
rate
set
mlmin
detect
wavelength
nm
calibr
curv
emodin
show
good
linear
mgml
rang
r
emodin
extract
g
polygonum
cuspidatum
mg
term
dri
start
materi
puriti
emodin
three
independ
experi
test
cytotox
emodin
cell
bromid
mtt
assay
shown
tabl
toxic
emodin
cell
highest
nontox
concentr
around
sever
report
shown
emodin
activ
multipl
viral
infect
initi
test
abil
emodin
inhibit
entri
replic
cell
report
emodin
cell
hbv
cell
first
infect
treat
differ
concentr
emodin
virusinduc
cytopath
effect
cpe
delay
dramat
emodin
concentrationdepend
manner
figur
shown
tabl
emodin
determin
mtt
plaqu
reduct
assay
pra
respect
select
index
si
emodin
evalu
mtt
pra
respect
inhibitori
effect
emodin
infect
equival
convent
antivir
ribavirin
signific
differ
si
emodintr
group
ribavirintr
group
p
determin
whether
inhibit
entri
replic
emodin
also
time
depend
compound
ad
indic
time
h
postinfect
maximum
inhibitori
rate
could
observ
emodin
ad
h
postinfect
place
inocul
figur
publish
research
sever
investig
indic
mechan
antivir
activ
emodin
deriv
sourc
reli
direct
inactiv
infecti
viral
particl
investig
emodin
direct
inactiv
effect
particl
vari
concentr
emodin
incub
indic
time
prior
inocul
cell
howev
virucid
effect
could
observ
studi
maximum
inhibitori
rate
emodin
virucid
assay
inhibitori
activ
observ
cell
preincub
variou
concentr
emodin
sinc
inhibitori
rate
dosag
signific
differ
emodintr
group
viru
control
group
direct
inactiv
preincub
assay
p
quantit
real
time
pcr
qpcr
use
evalu
rna
level
figur
summar
number
copi
obtain
differ
treatment
normal
dehydrogenas
gapdh
observ
copi
emodin
group
express
lower
viru
control
group
p
result
corrobor
dose
depend
inhibitori
effect
emodin
infect
previou
data
show
could
induc
apoptosi
primari
neuron
assess
hypothesi
emodin
may
attenu
ongo
cell
death
apoptosi
cell
infect
cell
infect
incub
emodin
ribavirin
harvest
evalu
apoptot
chang
result
summar
figur
number
cell
annexinv
bind
almost
equal
apoptosi
rate
significantli
increas
cell
infect
viru
h
postinfect
apoptosi
rate
cell
treat
emodin
ribavirin
significantli
lower
infect
control
p
suggest
emodin
inhibit
apoptosi
induc
differ
emodin
ribavirin
p
treat
group
median
lethal
dose
emodin
determin
prior
viru
inocul
death
rate
oral
gavag
emodin
dosag
gkgd
respect
emodin
calcul
gkgd
pharmacokinet
emodin
ribavirin
determin
hplc
analysi
respect
pharmacokinet
model
emodin
ribavirin
fit
well
twocompart
model
plasma
level
emodin
mgkgd
rise
maximum
min
administr
cmax
half
life
h
plasma
concentr
ribavirin
rise
maximum
min
administr
cmax
half
life
h
clinic
sign
murin
infect
gener
appear
postinfect
observ
mice
especi
viru
control
chang
behavior
transient
state
hyperact
weight
loss
accompani
hunch
postur
progress
diminish
vital
observ
compar
placebotr
anim
emodintr
anim
die
later
appear
clinic
sign
delay
dosedepend
manner
shown
figur
surviv
rate
mgkgd
p
mgkgd
p
mgkgd
p
group
increas
dramat
compar
viru
control
group
mgkgd
mgkgd
emodintr
group
show
signific
differ
ribavirin
group
p
mgkgd
group
show
better
surviv
rate
mgkgd
group
p
figur
compar
viru
group
mtd
prolong
treatment
emodin
dosag
mgkgd
p
mgkgd
group
p
mgkgd
group
p
mtd
show
differ
among
mgkgd
mgkgd
emodintr
group
ribavirin
control
p
bodi
weight
anim
also
measur
consecut
day
figur
mice
infect
viru
without
treatment
exhibit
obviou
weight
loss
compar
uninfect
mice
p
howev
mice
treat
emodin
maintain
rel
steadi
weight
show
less
weight
loss
throughout
infect
group
treat
mgkgd
mgkgd
emodin
show
differ
ribavirintr
control
p
heart
weightbodi
weight
hwbw
ratio
infect
control
group
day
significantli
increas
compar
normal
control
group
howev
ratio
decreas
dramat
mice
treat
emodin
dosag
p
mgkgd
p
mgkgd
figur
chang
viru
titer
heart
infect
mice
differ
group
day
shown
figur
c
oral
gavag
emodin
dosag
mgkgd
significantli
reduc
viru
titer
heart
homogen
compar
viru
control
group
p
examin
myocardi
lesion
evalu
patholog
score
balbc
mice
treat
differ
dosag
emodin
compar
infect
control
group
damag
myocardium
reliev
score
necrosi
infiltr
decreas
significantli
emodin
treatment
dosag
infect
tabl
figur
assess
express
two
apoptosisrel
gene
mrna
protein
level
order
investig
effect
emodin
apoptosisrel
gene
vivo
postinfect
treat
group
compar
control
use
rel
quantif
method
mrna
express
level
mgkgd
emodin
treat
group
level
respect
respect
express
viru
control
figur
therefor
emodin
treatment
could
reduc
amount
mrna
level
dramat
increas
mrna
level
compar
control
p
mgkgd
p
mgkgd
group
treat
mgkgd
emodin
show
differ
ribavirintr
group
p
viru
control
heart
tissu
also
analyz
determin
express
apoptosisrel
protein
western
blot
shown
figur
treatment
emodin
mgkgd
notabl
decreas
express
level
upregul
express
antiapoptosi
protein
compar
nontreat
infect
group
result
suggest
emodin
could
alter
transcript
level
apoptosisrel
gene
vivo
polygonum
cuspidatum
purchas
hubei
medicin
materi
compani
wuhan
china
identif
authent
plant
confirm
profession
medicin
plant
expert
prof
keli
chen
depart
plant
chemistri
hubei
univers
tradit
medicin
hubei
china
extract
reflux
scheme
shown
figur
quantiti
emodin
determin
hplc
dionex
ultim
sunnyval
ca
usa
analysi
emodin
identifi
nmr
bruker
billerica
usa
follow
mhz
j
hz
j
hz
oh
mhz
human
laryng
carcinoma
cell
routin
grown
dmem
dulbecco
modifi
eagl
medium
supplement
fetal
calf
serum
gibco
langley
ok
usa
penicillin
iuml
streptomycin
lglutamin
coxsacki
viru
strain
maintain
laboratori
propag
cell
viru
titer
estim
cytopathogen
cell
induc
viral
infect
express
tissu
cultur
infecti
dose
mtt
cell
prolifer
assay
perform
describ
previous
briefli
cell
seed
plate
cultur
atmospher
incub
h
confluent
monolay
form
remov
growth
medium
twofold
serial
dilut
emodin
ribavirin
tianj
pharmaceut
co
ltd
tianj
china
ad
incub
h
cultur
medium
remov
thiazolyl
blue
tetrazolium
bromid
solut
sigmaaldrich
st
loui
mo
usa
ad
incub
h
purpl
precipit
fulli
visibl
formazan
dissolv
dimethyl
sulfoxid
dmso
quantit
convent
micropl
reader
nm
accord
manufactur
protocol
toxic
dose
cell
death
emodin
calcul
doserespons
curv
optic
densiti
odof
treat
cellsodof
untreat
cell
assay
perform
triplic
cell
grown
cell
cultur
plate
challeng
h
thoroughli
wash
unbound
viru
serial
twofold
dilut
emodin
ad
well
develop
cpe
monitor
daili
light
microscopi
virusinfect
untreat
cell
show
cpe
time
point
antivir
activ
concentr
measur
mtt
assay
percent
inhibit
calcul
follow
formula
percent
inhibit
odcompound
treat
group
odviru
control
odnorm
control
odviru
control
calcul
regress
analysi
doseinhibit
relationship
use
spss
select
index
si
evalu
follow
formula
si
direct
effect
emodin
infect
evalu
accord
protocol
describ
xiong
et
al
slight
briefli
viral
suspens
contain
either
incub
equal
volum
medium
contain
differ
concentr
emodin
drugfre
vehicl
h
respect
h
adsorpt
mix
suspens
remov
cell
monolay
rins
care
phosphat
buffer
solut
pb
maintain
test
medium
humidifi
atmospher
h
virucid
effect
determin
mtt
assay
follow
procedur
describ
confluent
monolay
cell
preincub
fresh
medium
presenc
absenc
emodin
h
cell
wash
pb
twice
challeng
h
viru
adsorpt
cell
rins
twice
pb
overlaid
dmem
typic
cpe
visibl
inhibit
viru
evalu
mtt
assay
antivir
activ
emodin
also
evalu
plaqu
reduct
assay
briefli
cell
seed
cultur
plate
incub
reach
least
confluenc
cell
infect
h
adsorpt
cell
wash
twice
prewarm
pb
overlaid
agaros
contain
complet
dmem
differ
concentr
emodin
ribavirin
cell
fix
formaldehyd
min
stain
crystal
violet
solut
plaqu
number
count
visual
examin
percentag
plaqu
inhibit
calcul
follow
protocol
describ
elsewher
time
addit
assay
perform
describ
elsewher
briefli
cell
seed
cultur
plate
costar
densiti
cellswel
h
cell
monolay
infect
h
unbound
viru
remov
monolay
pb
three
time
emodin
ribavirin
ad
well
concurr
infect
h
interv
h
infect
viru
titer
determin
plaqu
assay
describ
previous
total
rna
isol
use
trizol
reagent
invitrogen
carlsbad
ca
usa
accord
manufactur
instruct
random
primer
sangon
shanghai
china
use
revers
transcript
total
rna
mmlv
revers
transcriptas
promega
beij
china
cdna
obtain
revers
transcript
store
primer
pair
refer
refer
list
follow
bp
forward
primer
revers
primer
forward
primer
revers
primer
reaction
perform
biorad
instrument
use
sybr
green
realtim
pcr
master
mix
reagent
toyobo
japan
realtim
pcr
reaction
perform
initi
denatur
min
threestep
cycl
procedur
denatur
anneal
extens
cycl
end
reaction
perform
triplic
result
normal
gapdh
fluoresc
emiss
cycl
monitor
analyz
use
bioraid
cfx
manger
softwar
apoptot
cell
assess
flow
cytometri
use
annexinvpropidium
iodid
pi
apoptot
kit
accord
manufactur
protocol
promega
brief
cell
infect
treat
emodin
h
float
cell
collect
centrifug
g
min
cell
pellet
wash
twice
ice
cold
pb
resuspend
bind
buffer
contain
fitcconjug
annexinv
antibodi
pi
min
room
temperatur
dark
apoptot
cell
determin
cytometri
data
analyz
use
cell
quest
softwar
epic
altra
ii
beckman
brea
ca
usa
balbc
mice
purchas
anim
research
center
wuhan
univers
certif
scxk
hubei
china
mice
handl
accord
guidelin
approv
institut
anim
care
use
committe
wuhan
china
nineti
male
balbc
mice
week
age
randomli
divid
six
group
mice
infect
intraperiton
inject
ml
salin
contain
mice
oral
administ
indic
dose
mgkgd
emodin
mgkgd
ribavirin
consecut
day
respect
salin
use
normal
viral
control
bodi
weight
death
record
day
eight
mice
group
sacrif
day
viral
inocul
cardiac
index
express
ratio
mean
heart
weight
mean
bodi
weight
heart
divid
two
part
one
part
homogen
dmem
determin
viru
titer
plaqu
assay
fix
histolog
examin
histopatholog
featur
myocard
includ
necrosi
inflamm
grade
semiquantit
score
necrosi
inflamm
foci
necrosi
inflamm
per
section
foci
foci
foci
confluent
area
necrosi
total
rna
extract
trizol
reagent
heart
invitrogen
revers
transcript
cdna
accord
manufactur
protocol
primer
design
primer
premier
softwar
list
follow
initi
denatur
step
min
threestep
cycl
procedur
carri
denatur
anneal
cycl
reaction
perform
least
duplic
sampl
rel
mrna
express
normal
level
gapdh
calcul
use
formula
describ
elsewher
infect
cardiac
muscl
tissu
either
untreat
differ
treatment
cut
centrifug
g
min
remain
tissu
homogen
lysi
buffer
centrifug
g
supern
mix
load
buffer
boil
min
centrifug
g
min
result
supernat
load
sdspolyacrylamid
gel
electrophoresi
transfer
nitrocellulos
membran
membran
block
dri
milk
solut
overnight
wash
twice
transbuff
without
methanol
incub
antibodi
mous
rabbit
mous
antigapdh
beyotim
institut
biotechnolog
co
ltd
nanj
china
membran
wash
incub
horseradish
peroxidaseconjug
secondari
antibodi
block
solut
protein
band
visual
enhanc
chemiluminesc
ecl
detect
system
set
experi
repeat
least
three
time
consist
result
data
analyz
spss
softwar
spss
inc
chicago
il
usa
data
vitro
experi
analyz
use
student
ttest
vivo
experi
analyz
use
logrank
test
surviv
rate
analysi
varianc
anova
mtd
kaplanmei
method
surviv
analysi
pvalu
consid
statist
signific
result
demonstr
potent
antivir
activ
emodin
inhibit
entri
replic
especi
first
h
postinfect
result
also
impli
emodin
may
act
biolog
synthesi
inhibitor
infect
rather
directli
inactiv
virus
block
absorpt
suscept
cell
inhibitori
effect
emodin
replic
confirm
qpcr
assay
equival
convent
antivir
ribavirin
ribavirin
synthet
nucleosid
structur
relat
inosin
guanosin
induc
lethal
mutat
incorpor
viral
rna
antimicrobi
mechan
emodin
howev
still
larg
unknown
previou
studi
reveal
emodin
may
directli
inhibit
host
cell
casein
kinas
essenti
phosphoryl
viral
protein
moreov
antivir
capac
emodin
envelop
virus
due
affin
phospholipid
membran
weak
hydrophob
interact
hydrocarbon
chain
phospholipid
bilay
emodin
also
inhibit
ion
channel
coronaviru
sarscov
well
viru
releas
valu
emodin
may
exert
antivir
activ
direct
inhibit
alkalin
nucleas
activ
find
suggest
emodin
may
potenti
antivir
candid
broad
spectrum
antivir
activ
target
virus
virusrel
protein
apoptosi
may
play
primari
role
pathogenesi
viral
infect
studi
emodin
could
also
mitig
apoptosi
vitro
vivo
rate
apoptosi
cell
treat
emodin
significantli
lower
viru
infect
control
differ
emodin
ribavirin
inhibit
apoptosi
furthermor
emodin
could
downregul
apoptosispromot
gene
upregul
apoptosisinhibit
gene
murin
heart
tissu
vivo
oral
administ
emodin
mgkgd
significantli
improv
mice
surviv
rate
prolong
mtd
decreas
hwbw
viru
titer
myocardi
patholog
score
caus
viru
infect
mgkgd
emodin
treatment
equival
mgkgd
ribavirin
allevi
viru
myocardi
lesion
properti
ad
appeal
emodin
potenti
therapeut
agent
infect
therewith
associ
myocard
